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Background: Craving is a core symptom of addictive disorders, such as pathological gambling for example. Over the
last decade, several studies have assessed the efﬁcacy of repetitive transcranial magnetic stimulation (rTMS) in the
addiction ﬁeld, which triggers the dorsolateral prefrontal cortex (DLPFC) to decrease craving. The STIMJEU study
investigated whether a single session of low-frequency (LF, i.e., 1 Hz) rTMS applied to the right DLPFC reduced cue-
induced gambling craving in a sample of treatment-seeking pathological gamblers.Methods: Thirty patients received
both active and sham rTMS in random order and were blinded to the condition in a within-subject crossover design.
Outcome measures included self-reported gambling craving (Visual Analog Scale and Gambling Craving Scale) and
physiological measures (heart rate and blood pressure). Results: The rTMS sessions were associated with a signiﬁcant
decrease in the gambling urge, regardless of whether the session was active or sham. When controlling cue-induced
craving levels, no effects were observed on craving for active rTMS. Overall, rTMS was well-tolerated, and the
credibility of the sham procedure was assessed and appeared to be appropriate. Conclusions: We failed to
demonstrate the speciﬁc efﬁcacy of one session of LF rTMS to decrease cue-induced craving in pathological
gamblers. A strong placebo-effect and rTMS parameters may partly explain these results. Yet, we are convinced that
rTMS remains a promising therapeutic method. Further studies are required to examine its potential effect.
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INTRODUCTION
As both the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV) and more recently the DSM-5 with
the new term “gambling disorder” describe, pathological
gambling (PG) is characterized by persistent and recurrent
problematic gambling behavior leading to clinically sig-
niﬁcant impairment or distress (American Psychiatric
Association [APA], 1994, 2013). The key features of PG
include the loss of control over gambling and continued
gambling behavior, despite signiﬁcant harmful conse-
quences. As numerous publications have previously
described, the loss of control associated with addictions
can result in the presence of craving (c.f., Skinner &
Aubin, 2010). Craving is deﬁned as a pressing, urgent,
and irrepressible desire to give in to an addictive behavior.
Beyond the mere desire to gamble, craving also includes
the expectation of positive effects and the relief of
negative effects as a result of this action (Young &
Wohl, 2009). This persistent symptom is a consequence
of speciﬁc cues, both internal (e.g., affective state)
and external (e.g., visual stimuli), through classical con-
ditioning (Koob & Volkow, 2010; Marhe, Waters, van de
Wetering, & Franken, 2013; Skinner & Aubin, 2010;
Sodano & Wulfert, 2010). Craving predicts relapse, even
after a long period of abstinence. Therefore, therapeutic
interventions must target this key symptom. The panel of
interventions proposed for PG is broad, including many
psychological interventions and pharmacological medica-
tions (Cowlishaw et al., 2012; Grant & Potenza, 2004;
Sauvaget et al., 2015). Importantly, psychological inter-
ventions remain as the preferred treatment choice, and
pharmacological interventions have smaller effect sizes
and mixed ﬁndings, the most robust of which were
obtained with opioid antagonists (Victorri-Vigneau
et al., 2017). To date, the literature supports the
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short-term efﬁcacy of speciﬁc interventions to reduce
gambling behaviors and other symptoms of PG. However,
the durability of this therapeutic gain is unknown.
Non-invasive brain stimulation [e.g., repeated transcra-
nial magnetic stimulation (rTMS), deep TMS, and tran-
scranial direct current stimulation] is a promising new
avenue of treatment in the addiction ﬁeld (Grall-Bronnec
& Sauvaget, 2014; Jansen et al., 2013; Protasio et al.,
2015; Sauvaget et al., 2015). Based on the principle of
electromagnetic induction, rTMS can modulate human
cortical excitability both at the site of stimulation and in
remote areas (Fox et al., 1997). Substance use disorders
(SUDs) and, to a lesser extent, food cravings, and certain
forms of eating disorders were the main addictive dis-
orders addressed in trials to assess the efﬁcacy of neuro-
modulation techniques in reducing cravings. Cravings are
underpinned by the activation of the reward and motiva-
tion circuits, involving, among others, the dorsolateral
prefrontal cortex (DLPFC) (Goldman et al., 2013; Jansen
et al., 2013; McBride, Barrett, Kelly, Aw, & Dagher,
2006; Volkow, Wang, Tomasi, & Baler, 2013; Wang
et al., 2007; Wing, Bacher, Wu, Daskalakis, & George,
2012). Previous studies have shown that craving is asso-
ciated with the hyperactivity of the right DLPFC (Wang
et al., 2007). Moreover, the functional magnetic resonance
imaging data have shown that pathological gamblers have
an overactive right DLPFC compared with healthy parti-
cipants after inducing craving with visual stimulation
(Crockford, Goodyear, Edwards, Quickfall, & el-Guebaly,
2005; Van Holst, Van den Brink, Veltman, & Goudriaan,
2010). Consequently, inhibiting an overactive right
DLPFC with low-frequency (LF) rTMS might decrease
cravings. Therefore, rTMS applied to the DLPFC might
indirectly modulate dopaminergic pathways (Addolorato,
Leggio, Hopf, Diana, & Bonci, 2012) and consequently
affect the symptoms of addiction (Feil & Zangen, 2010;
Keck et al., 2002). Evidence is growing regarding the
effects of rTMS applied to the DLPFC with regard to
craving among people with substance dependence and
cravings for highly palatable food (Grall-Bronnec & Sau-
vaget, 2014; Jansen et al., 2013; Protasio et al., 2015;
Sauvaget et al., 2015).
To date, only two studies have evaluated the effect of
rTMS in patients with gambling behavior. The ﬁrst study
tested the efﬁcacy of rTMS on gambling urges in nine men
with PG. The authors demonstrated that one active high-
frequency (HF) rTMS was associated with a reduced post-
game increase in the “desire to gamble” compared with a
sham treatment (Zack et al., 2016). The second study used a
randomized sham-controlled crossover design to examine
22 patients seeking treatment for gambling disorder. The
authors concluded that a single session of HF rTMS applied
over the left DLPFC reduced cue-induced cravings (Gay
et al., 2017). Another exploratory, open-label study using
deep TMS was conducted among ﬁve individuals with PG
and did not show positive effects (Rosenberg, Klein, &
Dannon, 2013). We hypothesized that applying LF rTMS to
the right DLPFC would reduce cue-induced cravings. There-
fore, we conducted a randomized, double-blind, sham-
controlled crossover study to test whether a single application
of LF rTMS over the right DLPFC, compared with sham
stimulation, would temporarily reduce cue-induced cravings
among treatment-seeking pathological gamblers.
METHODS AND MATERIALS
Participants
This STIMJEU (STIM: stimulation; JEU: gambling) study
examined pathological gamblers (deﬁned as those with ≥5
of the DSM-IV diagnostic criteria for this condition), aged
18–70 years, who were seeking treatment at our outpatient
department. Only right-handed patients were recruited given
that handedness might affect rTMS research, as previously
shown by Van den Eynde et al. (2010). During the ﬁrst part
of the recruitment period, only men were included because
men predominated in the samples of outpatients seeking
treatment. Finally, the research protocol was amended
so that women were also eligible if they were not pregnant.
In fact, women were accounted for a portion of the target
population. Participants were excluded if they showed
current alcohol or SUD (excluding that for nicotine),
according to the DSM-IV, showed cognitive impairment,
had difﬁculties in reading and writing in French, were
pregnant, had previous rTMS treatment, had metal implants
(e.g., pacemakers, metal plates, or wires), or had histories of
neurological disease, epilepsy, brain injury, or brain surgery.
Individuals taking medication likely to modify their seizure
threshold (psychotropic medication that had not been stable
for at least 7 days or benzodiazepine regardless of the
duration) were also excluded.
Experimental design
This STIMJEU study used a randomized, double-blind,
sham-controlled, crossover design to investigate the effect
of rTMS on cue-induced gambling craving. One of the
important advantages of a crossover design (i.e., a repeated/
longitudinal measurement design), which features both a
parallel study and a non-crossover longitudinal design, is
that the inﬂuence of confounders is reduced because each
patient serves as his or her own control. This study was
divided into two phases. Phase 1 aimed to verify whether
exposure to gambling cues signiﬁcantly induces craving. In
fact, we considered it as inconsistent to include patients in
whom craving could not be induced. Phase 2 applied one
active and one sham rTMS sessions, with a 1-week interval
to avoid any carryover effect. Figure 1 illustrates the study
design.
Phase 1: Inclusion of patients with cue-induced craving.
All patients underwent a semi-structured clinical interview
and completed self-report questionnaires. Well-trained and
experienced staff members performed this assessment,
which included an evaluation of craving [intensity at base-
line, measured using a Visual Analog Scale (VAS)]. For
5 min, the patients were then exposed to speciﬁc gambling
cues and selected based on their own preferred game and
their usual game medium (online or ofﬂine) to maximize
craving induction. We applied a broad range of visual and
audio stimuli to cover the diversity of the gamblers’ pre-
ferred game. For example, specialized press-and-blank
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betting grids were given to horse-race bettors, who also
watched a race broadcasted the day before. One poker player
connected to his gambler’s account on his preferred poker
website. The participants were asked to imagine that they
were in a real-life gambling situation, ready to bet money.We
ensured that the stimuli did not induce alcohol or other
substance cravings. Immediately after cue exposure, partici-
pants provided subjective ratings on a VAS. They were
“deﬁnitely” included in the study, if the intensity signiﬁcantly
increased (i.e., by at least 50% compared with baseline).
In other words, we only included patients with high reactivity
to gambling cues. Finally, they were randomly allocated
to the “active/sham” group or to the “sham/active” group
through a web-based randomization program.
Phase 2: Brain stimulation. Patients were asked to return
1 week later for the ﬁrst rTMS session. According to the
crossover design, each patient received one active and one
sham rTMS sessions in a random order with a 1- to 2-week
interval. The wash-out period was based on a compromise
among several elements: the transitory effect of rTMS on
craving, the need to minimize drop-outs, and the need not to
delay the start of treatment (which might bias the results) on
the one hand as well as the need to avoid a carry-over effect
and the availability of the patient, investigator, and rTMS
equipment on the other hand. This choice was supported by
the recent crossover studies conducted to assess the effect of
rTMS on alcohol (Herremans et al., 2012) and food (Barth
et al., 2011) cravings.
Following the motor threshold determination and the
identiﬁcation of the target site, a baseline measurement was
performed on the patients. They were then exposed to the
same individual gambling cues used during Phase 1 to induce
craving. They immediately received the ﬁrst rTMS session,
when the craving level was at the highest, to maximize the
effect of the neuromodulation technique. In fact, it was
assumed that the induction of craving immediately prior to
the rTMS session would create a more speciﬁc disruption of
the circuits associated with craving (Amiaz, Levy, Vainiger,
Grunhaus, & Zangen, 2009). The second rTMS session was
planned within the next 7–14 days. This session followed the
same procedure. At the end of the study, the patients were
paid with €175 worth of gift vouchers for their participation.
Three investigators (AS, SB, and JMV) performed the
rTMS and MGB supervised patient recruitment, the gam-
bling challenge task, and questionnaire completion. MGB
and participants were blind to the rTMS (active or sham)
allocation.
rTMS procedure
Justiﬁcation of the technical procedure. For the sake of full
clarity, when we designed this study, the three pilot studies
mentioned (Gay et al., 2017; Rosenberg et al., 2013; Zack
et al., 2016) were not yet published. We chose the para-
meters based on the existing literature on the subject
(Wang et al., 2007) and the safety guidelines concerning
the use of rTMS (Rossi, Hallett, Rossini, & Pascual-Leone,
2009).
Determination of the resting motor threshold (rMT) and
cortical target location. Following the mapping of the
abductor pollicis brevis site in the right motor cortex, each
patient’s rMT was established as the minimum stimulus
required to induce the contraction of the right thumb at least
5 out of 10 times (Pridmore, Fernandes Filho, Nahas,
Liberatos, & George, 1998). The site for stimulation of the
right DLPFC was determined following the Beam’s method
(Beam, Borckardt, Reeves, & George, 2009). At the second
visit, the rMT procedure was repeated, and the TMS coil
was located at the same site as at visit 1.
Participants were then ﬁtted with two electrodes on their
scalps just below the hairline and at the chin. Electrodes
were connected to an Eco 2 transcutaneous electrical nerve
stimulation device (TENS). During the rTMS, participants
were instructed to close their eyes and relax.
Active rTMS procedure. The Magpro R30-incl. MagOp-
tion, along with real and sham ﬁgure-eight coils, was used to
administer rTMS. Participants received frequency of 1 Hz at
120% rMT, with one train producing 360 pulses in a single
6-min session. The shortest session was elicited, given the
hypothesis that craving intensity naturally diminishes over
the course of a few minutes, and this decrease might instead
be incorrectly attributed to a speciﬁc effect of the rTMS
(Grall-Bronnec & Sauvaget, 2014). For active rTMS, the
TENS was turned off (no current ﬂowed through the scalp
electrodes).
Sham rTMS procedure. Placebo stimulation was applied
at the same location and frequency using the Magstim
sham-coil system. For sham rTMS, the TENS was turned
on at a frequency of 1 Hz and an intensity able to move
the periorbital and chin muscles. To ensure the validity
of the sham procedure, the same investigator performed
both the active and sham procedures. Moreover, at the end
of the second session (whether active or sham, depending on
Figure 1. STIMJEU study design
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the randomized order), participants were asked three ques-
tions: (a) Are you able to tell which was the real session and
which was the sham session?, (b) If so, when do you think
you received these treatments?, and (c) How were you able
to tell the difference?
Measures
Sociodemographic characteristics. We collected age and
gender information.
Evaluation of craving. Craving was assessed by a VAS
(the primary outcome), a gambling-related craving ques-
tionnaire, and physiological measures (the secondary out-
comes). Outcome measures were tested at several time
points: at baseline, immediately after gambling cue expo-
sure/before the rTMS session, immediately after the rTMS
session, and every 5 min until the craving intensity returned
to the baseline level.
Visual Analog Scale (VAS). In accordance with the
previous studies (Grall-Bronnec & Sauvaget, 2014), the
urge to gamble was measured using a 10-cm VAS, ranking
patients’ response to the question “how much do you want to
gamble right now?.” The VAS is an easy-to-use, sensitive,
reproducible, and reliable instrument.
Gambling Craving Scale (GACS). The GACS is a
multidimensional scale measuring gambling-related craving
comprising three subscales: anticipation, desire, and relief
(Young & Wohl, 2009). It is a nine-item scale, with three
items for each subscale. For the purpose of this study, we
only used the three items from the desire factor (“I crave
gambling right now,” “I need to gamble now,” and “I have
an urge to gamble”), which represents a strong and urgent
desire to gamble. In fact, the two remaining factors are more
likely to reﬂect gambling motives.
In accordance with the previous studies, we assumed that
craving assessment by a self-rated measure demonstrated
high validity (Herremans et al., 2012).
Physiological measures. Heart rate and blood pressure
were recorded. These measures are associated with physio-
logical arousal and are considered as proxy measures of
gambling craving (Ashraﬁoun & Rosenberg, 2012; Skinner
& Aubin, 2010). They were relevant in this context, because
they are objective and therefore complementary to the above
subjective measures.
Gambling characteristics
DSM-IV PG section. Patients were included in the STIMJEU
study through an interview based on the 10 DSM-IV diag-
nostic criteria for PG (APA, 1994). This categorical approach
was completed using a dimensional approach by adding the
number of positive DSM-IV criteria. Indeed, the number of
diagnostic criteria met is correlated with the severity of the
disorder (Toce-Gerstein, Gerstein, & Volberg, 2003).
Gambling-Related Cognitions Scale (GRCS). The GRCS
is a 23-item self-report scale that assesses a range of
gambling-related cognitive biases and errors: illusion of
control (GRCS-IC), predictive control (GRCS-PC), inter-
pretative bias (GRCS-IB), gambling-related expectancies
(GRCS-GE), and perceived inability to stop gambling
(GRCS-IS) (Raylu & Oei, 2004).
Gambling habits. The participants were asked to deﬁne
their favorite type of game, according to the classiﬁcation
proposed by Boutin (2010), and the medium usually used
for gambling (online or ofﬂine).
Clinical characteristics
Mini International Neuropsychiatric Interview (M.I.N.I.).
The ﬁfth version of the M.I.N.I. allows for the main axis-I
psychiatric disorders of the DSM-IV and antisocial per-
sonality disorder to be explored in a quick and standard-
ized way (Lecrubier et al., 1997). We used it to verify that
the patients met the eligibility criteria, especially with
regard to alcohol and SUDs.
Tolerability.A follow-up phone call was made 24 hr after
the session to check whether side effects had occurred.
Patients were excluded if a serious side effect occurred
during a session or if they had used any psychoactive
substance (excluding nicotine or their usual medication)
within 12 hr prior to the session.
Statistical analysis
The main analysis followed the intent-to-treat principle (all
randomized patients were analyzed according to their ran-
domization groups). Descriptive statistical analyses were
provided at baseline for categorical (number and percent-
age) and continuous (min–max, mean, median, and inter-
quartile range) data.
An analysis of covariance (ANCOVA) controlling
for baseline scores was performed including treatment,
period, and interaction between period and treatment
effects. Interaction between baseline scores and treat-
ment effects was also included in the ANCOVA model
to check that the treatment effect was not different
according to the baseline score level. All models were
validated using graphical residual analysis.
A power calculation indicated that 42 participants were
required to detect a 2-point difference on the VAS for
intergroup craving, with the standard deviation of the period
differences assumed as 3.5 with 95% power and a two-tailed
α of 0.05.
Ethics
The study was conducted in accordance with Good Clinical
Practice Guidelines and the Declaration of Helsinki, with
approval from the local ethics committee. Written informed
consent was collected from all participants.
RESULTS
Description of the participants
As Figure 2 shows, 112 problem gamblers called our
department to make an appointment between March 2012
and December 2014. A total of 100 individuals were
screened for this study, and 47 met the inclusion criteria.
The reasons for non-inclusion are summarized in Table 1.
Finally, 31 patients were enrolled, one of whom dropped out
just before receiving the ﬁrst treatment. Thirty completed
the study and received two rTMS sessions. The baseline
characteristics of the sample are described in Table 2.
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Immediate rTMS effects on craving
As Figure 3 shows, the neuromodulation sessions were
associated with a signiﬁcant decrease in the primary out-
come “urge to gamble” (active session: p value= .0003 and
sham session: p value< .0001). However, the “Active
rTMS” and “Sham rTMS” groups showed no difference
with regard to score change ( p value= .18). These results
were adjusted to the level of cue-induced craving assessed
using the VAS ( p value< .0001). The interaction between
the baseline score and the treatment effect was not signiﬁ-
cant (p value= .71) and was removed from the ANCOVA
model. Importantly, no interaction was found between
period and treatment ( p value= .94). In other words, the
order of rTMS sessions did not affect the blinding of the
sham versus active rTMS sessions.
Furthermore, the change in the secondary outcomes
GACS-desire, heart rate, and systolic/diastolic blood
pressure did not signiﬁcantly differ between the two groups
(p values = .70, .63, .36, and .43, respectively; Table 3).
Figure 2. Flow chart of the STIMJEU study
Table 1. Frequency of non-inclusion criteria
Number of
patients
Screened 100
Eligible 47
Non-eligible 53
Non-inclusion criteria
Current AUD or SUD 16
Women (during the ﬁrst part of the
enrollment period)
10
Non-attendance to the inclusion visit 7
rTMS contraindication (seizure and
Parkinson’s disease)
6
PG DSM-IV diagnostic criteria <5 6
Left-handed 4
Current benzodiazepine medication 3
Age ≥70 years 1
Note. AUD: alcohol use disorder; PG: pathological gambling;
SUD: substance use disorder; rTMS: repetitive transcranial mag-
netic stimulation.
Table 2. Baseline characteristics of the patients according to their randomization group
Median [lower quartile (Q1)−upper quartile (Q3)] or number (%)
Group 1 active rTMS–sham rTMS (n= 15) Group 2 sham rTMS–active rTMS (n= 16)
Sociodemographic characteristics
Sex (% males) 14 (93.33%) 13 (81.25%)
Age (years) 33 (28–42) 39 (34.5–56)
Gambling characteristics
Favorite type of game
“Pure chance games” 6 (40.00%) 7 (43.75%)
“Chance games with pseudo skills” 4 (26.67%) 8 (50.00%)
“Chance games with elements of skills” 5 (33.33%) 1 (6.25%)
Usual medium of game
Ofﬂine 10 (66.67%) 13 (81.25%)
Online 5 (33.33%) 3 (18.75%)
Severity of pathological gambling
(number of DSM-IV diagnostic criteria)
7 (6–8) 6 (5–7)
(Continued)
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Credibility of the sham rTMS procedure
About 29 of the 30 participants answered the three
questions assessing the validity of the sham procedure.
About 10 patients admitted that they were unable to
tell the difference between the active and the sham
sessions, whereas the remaining 19 asserted the opposite.
Of these patients, 7 failed to identify the nature of
the sessions, but 12 succeeded; 10 guessed the order of
the sessions based on how their skin felt and 2 based
on the differential effect that the sessions had on their
craving.
Table 2. (Continued)
Median [lower quartile (Q1)−upper quartile (Q3)] or number (%)
Group 1 active rTMS–sham rTMS (n= 15) Group 2 sham rTMS–active rTMS (n= 16)
Disease history (years) 5 (2–9) 9 (5–17)
Gambling-related cognitions
GRCS total score (/161) 79 (66–95) 85 (72–104)
GRCS-GE (/28) 16 (14–21) 14 (12–22)
GRCS-IC (/28) 4 (4–8) 7 (4–17)
GRCS-PC (/42) 20 (16–24) 22 (16–26)
GRCS-IS (/35) 27 (17–29) 25 (20–29)
GRCS-IB (/28) 17 (11–23) 18 (10–20)
Craving
Baseline 3.00 (1–5) 4.25 (1.25–5.25)
Cue-induced 7.00 (6–10) 8.5 (6.5–10)
Note. GRCS: Gambling Related Cognitions Scale; GRCS-GE: GRCS-Gambling-related Expectancies; GRCS-IC: GRCS-Illusion of Control;
GRCS-PC: GRCS-Predictive Control; GRCS-IS: GRCS-Inability to Stop gambling; GRCS-IB: GRCS-Interpretative Bias; rTMS: repetitive
transcranial magnetic stimulation.
Figure 3. Evolution of the craving intensity according to the active versus sham rTMS sessions
Table 3. Effect of the rTMS on the primary and secondary outcome measures
Active rTMS (N= 30) Sham rTMS (N= 30)
Mean (standard deviation) p value
VAS: “urge to gamble” (0–10) 2.62 (±0.33) 3.25 (±0.33) .18
GACS: “desire” factor (1–7) 1.89 (±1.14) 1.97 (±1.14) .70
Heart rate (bpm) 76.38 (±1.50) 77.40 (±1.47) .63
Systolic blood pressure (mmHg) 131.89 (±1.73) 134.21 (±1.73) .36
Diastolic blood pressure (mmHg) 82.63 (±1.11) 83.87 (±1.11) .43
Note. GACS: Gambling Craving Scale; VAS: Visual Analog Scale; rTMS: repetitive transcranial magnetic
stimulation.
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Procedure safety
No serious adverse reactions were observed during the
study. Around 17 patients reported one or several non-
serious (and mostly expected) adverse reactions, including
headache (17 times), unpleasant sensations (4 times), anxi-
ety (once), asthenia (once), sleep disturbance (once), nausea
(once), and foot muscle cramps (once).
DISCUSSION
This study examined the effect of a single LF rTMS session
applied to the right DLPFC on cue-induced craving among a
sample of pathological gamblers seeking treatment. To the
best of our knowledge, the STIMJEU study is the ﬁrst
crossover, randomized, and controlled rTMS trial to be
conducted and has the largest sample size of this type of
addicted patients (30 patients). In fact, the sample size of the
rTMS studies among patients with SUD is 22.2 on average
(Jansen et al., 2013), and previous TMS studies in the
gambling ﬁeld included 5 (Rosenberg et al., 2013), 9 (Zack
et al., 2016), and 22 (Gay et al., 2017) patients.
Effect of rTMS on gambling craving
The neuromodulation sessions were associated with a sig-
niﬁcant decrease in the urge to gamble, regardless of
whether the session was active or sham rTMS. After con-
trolling for cue-induced craving level, no effects were
observed for active rTMS on craving.
To explain the unspeciﬁc treatment effect of this study,
several hypotheses can be considered, especially regarding
the placebo effect, the natural course of craving, and the
stimulation parameters. First, a high placebo response is
frequently reported among clinical addiction trials (Litten
et al., 2013), especially concerning PG (Grant, Odlaug, &
Schreiber, 2014). Low symptom severity and short disease
history, which were the cases for the current participants, are
strong predictors of the placebo response (Weimer, Colloca,
& Enck, 2015). For these reasons, we assume that the
placebo effect was strong, which might explain why we
were unable to demonstrate a signiﬁcant difference between
sham and active rTMS, most likely because of a lack of
power. In the case of a high placebo effect, a signiﬁcant
difference between the active and placebo treatment is more
difﬁcult to demonstrate. This strong placebo effect matches
the previous results by Rosenberg et al. (2013) where rapid
but short-lasting effects were primarily considered as a sham
effect. Second, although we ensured that the sessions were as
brief as possible, we cannot exclude the fact that craving
decreased rapidly and spontaneously. In effect, the natural
course of craving remains poorly understood and ﬂuctuates
over time under the inﬂuence of many factors (Grall-Bronnec
& Sauvaget, 2014). However, previous studies have shown
that craving can remain strong up to 150 min after a
substance-cue presentation and then gradually decrease in
intensity (Heishman, Lee, Taylor, & Singleton, 2010;
Lundahl & Greenwald, 2016). We hypothesize that, in
our sample, the natural course of craving was highly
heterogeneous and patient-dependent. Another possible
explanation of the fact that both active and sham rTMS
resulted in decreased craving regarding the time course of
craving is the phenomenon of regression toward the mean.
Indeed, as the rTMS was applied at the moment when the
craving level was at the highest, the next measure of the
craving level was very likely to decrease at a later time point.
Considering a “random” time point in the course of craving
when applying rTMS would be an interesting alternative for
future studies to avoid this bias. Third, the stimulation
parameters might not have been optimal, especially the
number of pulses, leading to an insufﬁcient therapeutic effect
(Grall-Bronnec & Sauvaget, 2014). Similarly, the choice of
the treatment location (right DLPFC) and frequency (LF) can
give rise to some criticism. According to previous authors,
the increased activation of the DLPFC is associated with
cognitive control, whereas cue exposure and craving are
associated with increased activity in the regions implicated in
emotion (Goudriaan, de Ruiter, van den Brink, Oosterlaan, &
Veltman, 2010; Kober et al., 2010). Inhibiting the right
DLPFC through LF rTMS might reduce the cognitive regu-
lation of craving, thereby explaining the negative ﬁndings of
our study. However, craving did not increase after rTMS in
our study. Crockford and his colleagues demonstrated that
PG participants exhibited increased activity in the right
DLPFC when exposed to visual gambling sensory cues
(which was the case in this study). Those authors assumed
that the cues, through the activation of DLPFC networks,
involved the use of working memory in coding external
events into internal representations and volitional scanning
(Crockford et al., 2005).
Our ﬁndings conﬂict with the previous studies that
assessed the efﬁcacy of rTMS in the ﬁeld of addictions but
corroborate those of others (Barth et al., 2011; Herremans
et al., 2012; Hoppner, Broese, Wendler, Berger, & Thome,
2011; Van den Eynde et al., 2010; Walpoth et al., 2008). To
the best of our knowledge, only three studies have explored
the effects of TMS in pathological gamblers (Gay et al.,
2017; Rosenberg et al., 2013; Zack et al., 2016). Rosenberg
and colleagues were the ﬁrst to explore the neuromodulation
treatment option for PG in an open-label study. Five patients
underwent 15 sessions of LF (1 Hz) deep TMS to the left
DLPFC with an H-coil. Despite initial improvement, the
authors failed to demonstrate treatment efﬁcacy (Rosenberg
et al., 2013). The small sample size, the treatment para-
meters (including treatment location and frequency), the
lack of a control condition, and the possible inhibition of the
right DLPFC were cited as limitations. In a recent study,
Zack and colleagues explored the respective effects of one
session of HF rTMS on the medial PFC and one session of
continuous theta burst stimulation (cTBS) on the right
DLPFC with regard to decision making, cognitive control,
gambling reinforcement, and physiological arousal. Nine
participants received active or sham treatments at weekly
intervals. A slot machine was used as the reinforcing
stimulus. The authors found that both rTMS and cTBS
reduced gambling reinforcement but not impulsive choice.
Relative to sham, active rTMS reduced the post-game
increase in craving. These latter results are not in line with
ours, although the authors inhibited the right DLPFC in one
arm of their study. However, they did not directly evaluate
the effect of rTMS on craving. Finally, a recent study of
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patients with gambling disorder reported decreased
cue-induced cravings following a single session of HF
rTMS applied over the left DLPFC (Gay et al., 2017).
However, the authors failed to show a signiﬁcant effect of
rTMS on gambling behavior. A comparison between the
ﬁndings of these three studies and ours must be made
carefully because of the different frameworks (clinical vs.
experimental) and the different designs of the studies
(stimulation before or after gambling-cue exposure, type
of TMS, LF vs. HF rTMS, etc.).
Credibility of the sham procedure
Only 12 of 30 patients guessed the order of the sessions
correctly, suggesting that the sham condition was reasonably
matched to the real TMS, with respect to face and scalp
sensations. This rate is in keeping with previous results (40%)
(Barth et al., 2011) but lower than other results reported with
regard to rTMS randomized clinical trials of patients with
depression (more than 50%) (Berlim, Broadbent, & Van den
Eynde, 2013) and higher than the results of Gay et al. (2017),
who found that less than 25% of the participants correctly
guessed the rTMS allocation, even though they used the same
sham method as ours. These discrepancies suggest that both
human and technical factors inﬂuence the patients’ ability to
identify the difference between sham and active sessions.
To better explore this phenomenon, we asked the patients to
justify their choice. A large majority based their decision on
skin sensations, suggesting the inﬂuence of the placebo effect.
These ﬁndings suggest that it is difﬁcult to develop a reliable
sham rTMS method, and this result should be reported along
with the blinding success rate in any randomized control trial
using rTMS. Moreover, because current sham methods might
inadequately mimic real rTMS, the blinding and bias estima-
tions of the treatment effects might be only partially successful
(Broadbent et al., 2011). The expression of craving is emi-
nently subjective, and its intensity can be over- or under-
estimated if the placebo method has not been optimized
(Brunoni, Lopes, Kaptchuk, & Fregni, 2009). Thus, we cannot
exclude the possibility of signiﬁcant bias given the sham
method we used with regard to the results of this study.
Study strengths and weaknesses
These results must be viewed in the context of several
limitations, which were described above to explain the
negative results of our trial. We add that we failed to recruit
42 participants as indicated by the power calculation. How-
ever, we decided to end the study because of recruitment
difﬁculties (only 47 of 100 screened patients were eligible,
because we chose strict inclusion criteria to demonstrate a
speciﬁc effect of rTMS, and a quarter of those contacted had
refused to participate) and because our sample size
was signiﬁcantly larger than those of most other studies.
Nevertheless, it is possible that our analyses lacked power.
In addition, the number of patients who did not meet the
inclusion criteria suggests that the current results might
not be generalized to the entire population of pathological
gamblers. However, these limits are compensated by
the strengths of the study. As a precautionary measure,
only patients with high reactivity to gambling cues were
included, and the rTMS sessions were applied when the
craving level was at its highest to maximize the effect of the
neuromodulation technique. To the best of our knowledge,
previous studies on this topic have not veriﬁed whether the
patients were craving inducible. In this study, four patients
were not craving inducible and were therefore not included.
Furthermore, we planned to evaluate craving using several
methods to better capture the complexity of the craving
concept. This study assessed several dimensions: feelings,
cognitions, and physiological correlates. In a recent publica-
tion, we showed that most of the studies assessing the efﬁcacy
of rTMS on craving and addictive behaviors used a VAS
as an outcome measure and exclusively in 8 of 18 cases
(Grall-Bronnec & Sauvaget, 2014). Only three studies com-
bined several measures, both subjective and objective (Amiaz
et al., 2009; Eichhammer et al., 2003; Li et al., 2013). In
addition, patients with alcohol or other SUDs were not
eligible to avoid confusing the craving to gamble and that
for alcohol or other substances. This criterion represented the
main reason for non-inclusion in this study.
In conclusion, we failed to demonstrate the efﬁcacy of one
session of LF rTMS to decrease the cue-induced cravings of
pathological gamblers. Nevertheless, we are convinced that
rTMS remains a promising therapeutic method. Additional
studies with more patients are needed to examine the potential
effect of rTMS and determine the best technical parameters. A
placebo lead-in should be used to exclude placebo responders.
Furthermore, several daily sessions of rTMSmight be required
to induce long-lasting effects and change gambling behaviors.
In a previous review, we indicated that a design with repeated
daily sessions of rTMS over a period of several weeks should
be used in addictive disorders, considering that repeated,
frequent sessions will result in changes in cerebral neuroplas-
ticity and generate a long-lasting effect (Grall-Bronnec &
Sauvaget, 2014).
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